RT Journal Article SR Electronic T1 Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.11.18.20232546 DO 10.1101/2020.11.18.20232546 A1 Maria Cassia Mendes-Correa A1 Fabio E. Leal A1 Lucy S. Villas-Boas A1 Steven S. Witkin A1 Anderson de Paula A1 Tania Regina Tozetto-Mendonza A1 Noely Evangelista Ferreira A1 Gislaine Curty A1 Pedro Santos de Carvalho A1 Lewis F. Buss A1 Silvia F. Costa A1 Flavia Mendes da Cunha Carvalho A1 Joyce Kawakami A1 Noemi Nosomi Taniwaki A1 Heuder Paiao A1 Joao Carlos da Silva Bizário A1 Jaqueline Goes de Jesus A1 Ester Cerdeira Sabino A1 Camila Malta Romano A1 Regina Maura Zetone Grepan A1 Antonio Sesso YR 2020 UL http://medrxiv.org/content/early/2020/11/20/2020.11.18.20232546.abstract AB It has been estimated that individuals with COVID-19 can shed replication-competent virus up to a maximum of twenty days after initiation of symptoms. This report describes two patients with mild forms of the disease who shed replication-competent virus for 24 and 37 days, respectively, after symptom onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors involved in the manuscript or study design did not receive any kind oy payment for their service. The study was funded by Virology Laboratory from Instituto de Medicina Tropical-Faculdade de Medicina da Universidade de Sao Paulo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee (Comissao de Etica para Analise de Projeto de Pesquisa - CAPPesq, protocol No. 13915, dated June 03, 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is avaiable for consultation at any time.